290
Participants
Start Date
March 31, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
Pleiotropic info, in-person disclosure
"Individuals are provided with a lifetime percentage risk of developing Alzheimer's disease based on APOE genotyping as well as additional pleiotropic information.~Genetic counselors communicate results to participants during an in-person disclosure session."
AD-only info, in-person disclosure
"Individuals are provided with a lifetime percentage risk of developing Alzheimer's disease based on APOE genotyping.~Genetic counselors communicate results to participants during an in-person disclosure session."
Pleiotropic info, phone disclosure
"Individuals are provided with a lifetime percentage risk of developing Alzheimer's disease based on APOE genotyping as well as additional pleiotropic information.~Genetic counselors communicate results to participants during a telephone disclosure session."
AD-only info, phone disclosure
"Individuals are provided with a lifetime percentage risk of developing Alzheimer's disease based on APOE genotyping.~Genetic counselors communicate results to participants during an in-person disclosure session."
Howard University, Washington D.C.
Case Western Reserve University, Cleveland
University of Michigan, Ann Arbor
Boston University School of Medicine, Boston
National Human Genome Research Institute (NHGRI)
NIH
Brigham and Women's Hospital
OTHER